Skip to main content
. 2025 Jul 11;120:107464. doi: 10.1016/j.ultsonch.2025.107464

Table 2.

Trans-Epithelial Electrical Resistance (TEER) (Ω/cm2) of Calu-3 cells and aspirin distribution at 4 h after treatment by ASA-API, sample A3 and F6.

Sample TEER before deposition (Ω/cm2) TEER 4 h after deposition (Ω/cm2) 4 h cumulative drug permeated (%) Cell surface (%) Intracellular (%)
ASA-API 427 ± 15 407 ± 10 35.27 ± 4.31 38.95 ± 3.12 25.78 ± 0.45
A3 405 ± 12 403 ± 5 69.87 ± 4.60 11.50 ± 1.11 18.63 ± 0.55
F6 392 ± 7 379 ± 6 77.15 ± 2.79 10.73 ± 1.96 12.12 ± 0.84